GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Beginning Cash Position

Gubra AS (CHIX:GUBRAC) Beginning Cash Position : kr46.9 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Beginning Cash Position?

Gubra AS's Beginning Cash Position for the quarter that ended in Dec. 2024 was kr46.9 Mil.

Gubra AS's quarterly Beginning Cash Position declined from Dec. 2023 (kr83.5 Mil) to Jun. 2024 (kr53.4 Mil) and declined from Jun. 2024 (kr53.4 Mil) to Dec. 2024 (kr46.9 Mil).

Gubra AS's annual Beginning Cash Position declined from Dec. 2022 (kr115.8 Mil) to Dec. 2023 (kr71.9 Mil) and declined from Dec. 2023 (kr71.9 Mil) to Dec. 2024 (kr53.4 Mil).


Gubra AS Beginning Cash Position Historical Data

The historical data trend for Gubra AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Beginning Cash Position Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial 40.41 67.10 115.79 71.93 53.40

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only 90.48 71.92 83.50 53.40 46.91

Gubra AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Gubra AS Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Gubra AS's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS Business Description

Traded in Other Exchanges
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.

Gubra AS Headlines

No Headlines